{{Rsnum
|rsid=76262710
|Chromosome=10
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=RET
|position=43113648
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=RET
}}{{omim
|id=164761
|rsnum=76262710
|variant=0001
}}
{{omim
|id=164761
|rsnum=76262710
|variant=0025
}}{{ClinVar
|rsid=76262710
|Reversed=0
|FwdREF=T
|FwdALT=A,C,G
|REF=T
|ALT=A,C,G
|RSPOS=43609096
|CHROM=10
|dbSNPBuildID=131
|SSR=0
|SAO=1
|VP=0x050068000000000002110104
|GENEINFO=RET:5979
|GENE_NAME=RET
|GENE_ID=5979
|WGT=0
|VC=SNV
|CLNALLE=1; 2; 3
|CLNHGVS=NC_000010.10:g.43609096T>A; NC_000010.10:g.43609096T>C; NC_000010.10:g.43609096T>G
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=0
|CLNSRCID=164761.0025; 164761.0001
|CLNSIG=5
|CLNCUI=C1833921; C0025268
|CLNDBN=MEN2A and FMTC; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia, type 2a; MEN2A and Unclassified
|Disease=MEN2A and FMTC; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia; MEN2A and Unclassified
|CLNACC=RCV000032040.1; RCV000014954.24; RCV000021792.1; RCV000014919.20; RCV000021793.1
|Tags=PM;PMC;OTHERKG;LSD;OM;NOV
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet; GeneReviews:MedGen:OMIM:Orphanet:Orphanet:SNOMED_CT
|CLNDSDBID=NBK1257:C1833921:155240:653; NBK1257:C0025268:171400:247698:653:61808009
}}{{PMID Auto
|PMID=3078962
|Title=Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
}}

{{PMID Auto
|PMID=7907913
|Title=Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
}}{{PMID Auto
|PMID=8103403
|Title=Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
}}